The Center for Pediatric Inflammatory Bowel Disease at The Children's Hospital of Philadelphia is one of the largest centers of its kind in the United States.
We care for approximately 1,400 children a year with IBD, who come here from all over the world.
Our team of pediatric IBD experts gives your child expert care, from initial testing and diagnosis through long-term disease management.
Although there currently is no cure for Crohn's disease or ulcerative colitis, our innovative methods control symptoms and improve quality of life.
Your child will receive the latest treatments for pediatric inflammatory bowel disease, as well as intensive support from our team of physicians, psychologists, social workers, nutritionists, nurses, educators, pediatric surgeons, laboratory technicians and clinical researchers.
Because pediatric IBD places unique emotional demands on your child and family, you will receive the support and counseling you need to adapt to life with IBD.
We invite you to become part of the Center's support network by attending meetings and events where you can interact with others experiencing the same challenges.
Our researchers are actively involved in basic and clinical research studies. Our goal is to gain a better understanding of IBD's causes and processes, to find better treatments, and ultimately, to find a cure.
Your child has the opportunity to participate in these clinical studies and to benefit from any research advances that are applied to patient care.
Patients with inflammatory bowel disease (IBD) who are diagnosed at very young age, less than 5 years old, are known as very early onset IBD (VEO-IBD). These children often present with a different and more severe disease than older children and adults with IBD. Through advanced new technology, whole exome sequencing, we are studying the genetic pathways responsible for VEO-IBD. Our preliminary analysis suggests that there are rare genes that contribute to the development of this disease, and we are now studying these findings in a larger population. In addition, we have started to evaluate how these genes interact with the environment as a potential risk factor for the development of VEO-IBD. Our goal is to use this knowledge to find new and individual therapies for this unique disorder.
Contact the Center for Pediatric Inflammatory Bowel Disease.